New York, NY -- October 3, 2022 -- InvestorsHub NewsWire -- via Traders News Source, a leading independent equity research and corporate access firm focused on small cap growth companies issues new research reports.


September was a brutal month for many NASDAQ stocks including EV player Mullen Automotive, Inc. (NASDAQ: MULN). The company just announced their Mullen FIVE “Strikingly Different” U.S. tour where pre-registered people can test drive their Mullen FIVE EV Crossover. In Spring 2023, Mullen will launch the second leg of the “Strikingly Different” Tour with a focus on the East Coast, Midwest, and northwest. The second leg of the tour will feature the Mullen FIVE RS, which is a high-performance EV sport crossover, featuring 1,100 horsepower, a top speed of 200 mph and acceleration from 0-60 mph in just 1.9 seconds. With their lead product leronlimab already in late-stage clinical trials CytoDyn Inc. (OTCQB: CYDY) announced last week that it will refocus its leronlimab development on specific indications and abandon Covid-19 from its pipeline. Following difficulties with the FDA earlier in the year that placed some of their clinical trials on hold, CYDY has a new leader, Cyrus Arman, Ph.D., at the helm as President.


Will the tours around the country resuscitate MULN’s falling value? And can Cyrus Arman create a turnaround for CYDY?  READ MORE


Copy and paste to browser may be required



Sysorex, Inc. (OTCQB: SYSX), a provider of technology services to the U.S. government, and a leading Ethereum miner, has just had a shareholder vote that may result in a near term name change and a change in the company’s share structure. SYSX has a current market value of $1.48M but the Company’s assets and revenues are reported at much higher levels. In other news, the provider of nanoscience solutions and product development Industrial Nanotech, Inc. (OTCPNK: INTK) recently updated shareholders on its move to expand its business into Dubai. The company has created a plan acceptable to all participants to work together and establish the application protocols and certifications for the company’s existing products and cement the company’s position as a thought leader in the region for sustainable solutions.


What could the value of SYSX be based on valuation metrics and what is INTK developing in Dubai? READ MORE


Copy and paste to browser may be required






Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.




The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.




TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.




This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at:

Media Contact


Mark Roberts

SOURCE: Traders News Source


Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more CytoDyn (QB) Charts.
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more CytoDyn (QB) Charts.